Your session is about to expire
← Back to Search
Escitalopram for Brain Tumor
Study Summary
This trial will study the effects of SSRIs on grade IV glioma patients. Changes in cognition and psychosocial factors will be measured from before treatment to 17 weeks after treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently on an SSRI or SNRI antidepressant.I am a woman who is postmenopausal, had no periods for 2+ years, am sterilized, or will use two forms of birth control.I had side effects from SSRI or SNRI medications.I am about to start chemotherapy or radiation for my newly diagnosed condition.I am of childbearing age and have a negative pregnancy test.I can take care of myself and perform daily activities.I am 19 years old or older.I do not have partial vision loss.My kidney function is severely impaired.I have been diagnosed with a Grade IV brain tumor.
- Group 1: Escitalopram
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for individuals to join this experiment at the present?
"According to the clinicaltrials.gov webpage, this medical research project is currently looking for participants. This experiment was initially listed on March 6th 2019 and has recently been amended on July 27th 2022."
Have prior investigations occurred involving Escitalopram Oral Tablet?
"At this moment, 23 trials are underway to research Escitalopram Oral Tablet. 5 of those have reached Phase 3. The bulk of these experiments take place in Cincinnati, Ohio; however, 45 sites across the US are running similar studies for the same treatment."
Is Escitalopram Oral Tablet an innocuous medication for those taking it?
"Based on our assessment, escitalopram oral tablets have been rated a 2 out of 3 in terms of safety. This reflects their Phase 2 trial status with limited data supporting its efficacy but some that attest to its safety."
What is the aggregate population size of participants enrolled in this research endeavor?
"Affirmative. The clinical trial details featured on clinicaltrials.gov suggest that recruitment is still in progress for this medical study, which was first published on March 6th 2019 and recently updated on July 27th 2022. A total of 20 participants are needed from a single location."
Share this study with friends
Copy Link
Messenger